Why it Matters
The House Energy and Commerce Subcommittee on Health is scheduled to discuss growing medical prices, when it convenes Wednesday, June 10 for a hearing on policies to increase health care transparency. At stake is whether Congress will strengthen existing rules that critics say have done more to help hospitals negotiate higher reimbursements than to lower costs for patients.
Federal price transparency rules have been on the books for years, but their effectiveness is in dispute. A February 2026 NPR report found that published hospital pricing data may actually benefit providers more than patients — giving hospitals leverage to identify where they are being underpaid relative to competitors and demand higher rates from insurers, a dynamic that can push premiums up rather than down. The Centers for Medicare & Medicaid Services notified 27 hospitals between June 2022 and May 2025 that they faced fines for non-compliance with existing rules, suggesting enforcement has been uneven.
The Big Picture
A Forbes analysis published May 1 argued that transparent prices alone will not lower what patients actually pay out of pocket, given the complexity of how insurers process claims. A separate Forbes piece from May 20 pointed to a growing market for providers that post upfront prices directly to consumers, arguing that insurance adds complexity without adding value for routine care.
The Centers for Medicare and Medicaid Services began enforcing updated Hospital Price Transparency requirements on April 1, 2026, following a final rule that took effect Jan. 1. The new standards require hospitals to rely on standardized data sources, report more precise allowed-amount information, and submit executive attestations of accuracy. That enforcement rollout, less than two months before the hearing, gives the subcommittee a concrete regulatory development to examine.
The Committee will review the Patients Deserve Price Tags Act, introduced Sept. 26, 2025, by Rep. John James (R-MI), which would amend the Public Health Service Act across multiple fronts. Hospitals would be required to post all standard charges monthly in machine-readable format, including gross charges, discounted cash prices, and payer-specific negotiated rates. Beginning July 1, 2027, clinical diagnostic laboratories and imaging providers would face similar posting requirements for shoppable services.
On billing, the bill would require providers to send itemized bills within 30 days of receiving final payment and prohibit collections actions against patients who haven't received a compliant bill. The bill remains in the introduced stage with no further action beyond its initial committee referral.
The Bottom Line
The subcommittee is chaired by Rep. Morgan Griffith (R-VA-9) and Rep. Diana Harshbarger (R-TN-1) as vice chair.
The membership spans both parties and includes several members with medical backgrounds — among them Reps. Mariannette Miller-Meeks (R-IA-1), John Joyce (R-PA-13), Neal Dunn (R-FL-2), Kim Schrier (D-WA-8), and Raul Ruiz (D-CA-25) — which may shape how the subcommittee engages with questions about clinical pricing and the practical limits of consumer-facing transparency tools.